Screening for prostate cancer using upright MRI
Study Contact Information:
For additional information, please contact:
Study Director: Dara Lundon (212) 241-0751 [email protected]
This study will compare the effectiveness of an upright magnetic resonance imaging (MRI) compared to prostate specific antigen (PSA) and current MRI imaging for prostate cancer screening.
Participants will have a standard of care MRI as well as an upright, seated MRI. After each MRI, participants will be asked to fill out questionnaires to assess their comfort level during the scans. If something suspicious is found on either scan, participants may have an ultrasound guided biopsy of the prostate, a way to sample and test prostate tissue for cancer. Researchers will check in with the participants every 6 months for 5 years.
Icahn School of Medicine at Mount Sinai
Principal Investigator: Ash Tewari, MD
Contact: Dara Lundon (212) 241-0751 [email protected]
Ash Tewari: Icahn School of Medicine at Mount Sinai
Men 18 years and older who:
Those who do not meet the criteria defined above and individuals who:
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.